Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Hoffmann-La Roche
Age
2–19
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Primary renal transplant recipients between 2 and 19 years of age
Receiving or have received daclizumab in the previous 4-18 months
Receiving or have received daclizumab less than (\<) 24 hours pretransplant and additional courses every other week
Single organ recipients (kidney only)
Previous vaccination with tetanus toxoid (TT) prior to transplant
Receiving a maintenance immunosuppression regimen of a calcineurin inhibitor, mycophenolate mofetil, and prednisone (or equivalent corticosteroid)
You may not be if
Received intravenous gamma globulin or a TT vaccination since transplant
Experienced rejection within 3 months of receiving study vaccinations and/or treated with lymphocyte preparation or methylprednisolone to reverse suspected acute rejection within 3 months of receiving study vaccinations
Received any vaccine within 30 days of receiving study vaccinations
Received plasmapheresis treatment or growth hormone treatment since transplant
